We'd all like to invest as successfully as the legendary Warren Buffett. He calculates return on invested capital (ROIC) to help determine whether a company has an economic moat -- the ability to earn returns on its money beyond that money's cost.

ROIC is perhaps the most important metric in value investing. By determining a company's ROIC, you can see how well it's using the cash you entrust to it, and whether it's actually creating value for you. Simply put, ROIC divides a company's operating profit by the amount of investment it took to get that profit:

ROIC = Net operating profit after taxes / Invested capital

This one-size-fits-all calculation cuts out many of the legal accounting tricks (such as excessive debt) that managers use to boost earnings numbers, and provides you with an apples-to-apples way to evaluate businesses, even across industries. The higher the ROIC, the more efficiently the company uses capital.

Ultimately, we're looking for companies that can invest their money at rates that are higher than the cost of capital, which for most businesses lands between 8% and 12%. Ideally, we want to see ROIC greater than 12%, at minimum. We're also seeking a history of increasing returns, or at least steady returns, which indicate that the company's moat can withstand competitors' assaults.

Let's look at Bristol-Meyers Squibb (NYSE: BMY) and two of its industry peers to see how efficiently they use capital. Here are the ROIC figures for each company over several time periods:

Company

TTM

1 year ago

3 years ago

5 years ago

Bristol-Meyers Squibb

24.4%

22.3%

11.9%

19.7%

Biogen Idec (Nasdaq: BIIB)

19.5%

12.9%

15.3%

4.6%

Gilead Sciences (Nasdaq: GILD)

47.5%

38.6%

44.6%*

88.4%

Source: Capital IQ, a division of Standard & Poor's. *Uses 2007's effective tax rate.

Bristol-Meyers Squibb's return on invested capital well exceeds our desired 12%, and has more than doubled its ROIC from three years ago and is well up from five years ago, too. Biogen Idec also exceeds our 12% threshold and shows the type of steady growth we like to see, even though the year-ago figure was off. While Gilead Sciences has the highest ROIC of the three companies, its returns have declined by more than 40 percentage points in the past half-decade. Still, it seems to have shored up its ROIC in the past few years, a positive sign for investors.

Businesses with consistently high ROIC are efficiently using capital. They can use their extra returns to buy back shares, further invest in their future success, or pay dividends to shareholders. (Warren Buffett especially likes that last part.)

To unearth more successful investments, dig a little deeper than the earnings headlines, and check up on your companies' ROIC.

The Motley Fool is recommending 50 stocks in 50 days for its new "11 O'Clock Stock" series. For more information, click here. Then come back to Fool.com every single weekday at 11 a.m. ET for a brand-new pick!

Jim Royal, Ph.D., does not own shares in any company mentioned. Try any of our Foolish newsletter services free for 30 days. True to its name, The Motley Fool is made up of a motley assortment of writers and analysts, each with a unique perspective; sometimes we agree, sometimes we disagree, but we all believe in the power of learning from each other through our Foolish community. The Motley Fool has a disclosure policy.